» Articles » PMID: 9989123

Screening for Anxiety and Depression in Women with Breast Cancer. Psychiatry and Medical Oncology Gear Up for Managed Care

Overview
Journal Psychosomatics
Publisher Elsevier
Specialty Psychiatry
Date 1999 Feb 16
PMID 9989123
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, 275 women with breast cancer attending ambulatory breast cancer clinics in two sites were evaluated for psychological distress by using three self-report instruments: a visual analogue scale for psychological distress, the Hospital Anxiety and Depression Scale, and the Brief Symptom Inventory. Results suggest that significant psychological distress exists in ambulatory women with breast cancer; all three instruments effectively measured that level of distress. Implications for the use of these instruments in educating oncological staff members, documenting need for psychiatric services in a period of capitation, and providing quality assurance evaluations of psychiatric services are discussed.

Citing Articles

Talking control sessions in people with advanced cancer: a qualitative analysis of sessions.

Lamirel D, Davis S, Low J, Serfaty M, Armstrong M BMC Psychol. 2022; 10(1):126.

PMID: 35596193 PMC: 9121545. DOI: 10.1186/s40359-022-00837-1.


Psychiatric Symptoms and Psychosocial Problems in Patients with Breast Cancer.

Izci F, Ilgun A, Findikli E, Ozmen V J Breast Health. 2017; 12(3):94-101.

PMID: 28331743 PMC: 5351486. DOI: 10.5152/tjbh.2016.3041.


The impact of depression and anxiety on the quality of life in nonmetastatic breast cancer patients in postoperative evaluation.

Dragomir B, Fodoreanu L, Rancea A Clujul Med. 2015; 86(1):48-52.

PMID: 26527916 PMC: 4462482.


Exploring clinical determinants and anxiety symptom domains among Asian breast cancer patients.

Cheung Y, Lee H, Chan A Support Care Cancer. 2013; 21(8):2185-94.

PMID: 23475194 DOI: 10.1007/s00520-013-1769-8.


Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour.

Khan F, Amatya B J Neurooncol. 2013; 111(3):355-66.

PMID: 23292152 DOI: 10.1007/s11060-012-1024-z.